Adaptimmune Therapeutics
ADAP
#10764
Rank
A$20.31 M
Marketcap
A$0.07663
Share price
0.00%
Change (1 day)
-16.44%
Change (1 year)

Financial Reports

Thumbnail Adaptimmune Therapeutics Financial Report 2025

Financial Report 2025

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2022

Financial Report 2022

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2021

Financial Report 2021

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2020

Financial Report 2020

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2019

Financial Report 2019

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2018

Financial Report 2018

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2017

Financial Report 2017

Language: English

View Financial Report
Thumbnail Adaptimmune Therapeutics Financial Report 2016

Financial Report 2016

Language: English

View Financial Report